Blog

Jan 19, 2021

Mayo researchers explore genetics behind COVID-19 outcomes

By Susan Murphy @susanmurphy
Some patients with COVID-19 experience severe complications, such as organ damage, shortness of breath, neurological impairment and chronic fatigue. A team of researchers within Mayo Clinic Center for Individualized Medicine is contributing to the global effort of using advanced genetic sequencing to find out which genes influence disease outcomes. “Our findings [...]
Mayo researchers explore genetics behind COVID-19 outcomes
Jan 13, 2021

Convalescent plasma antibody levels and the risk of death from COVID-19

By Susan Murphy @susanmurphy
By Bob Nellis| ROCHESTER, Minn. – Mayo Clinic researchers and collaborators have found an association between administration of convalescent plasma containing high antibodies and lower mortality rates for hospitalized patients with COVID-19 who are not on ventilators. The findings, “Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19,” appear [...]
Convalescent plasma antibody levels and the risk of death from COVID-19
Jan 6, 2021

Researchers define best practices of genome sequencing for patients with rare diseases

By Colette Gallagher @colettegallagher
Genome sequencing has shown promise in becoming a first-tier diagnostic test for patients with rare genetic disorders, but standards addressing the definition and deployment of a best-in-class test are lacking. Two recent manuscripts published in npj Genomic Medicine present consensus recommendations on clinical genome sequencing analytical validation and clinical utility to [...]
Researchers define best practices of genome sequencing for patients with rare diseases
Contact Us · Privacy Policy